Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
Contact your MP or a Member of the House of Lords about an issue that matters to you
Sign up for the Your Parliament newsletter to find out how you can get involved
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Business, Energy and Industrial Strategy Committee
The deadline for submissions has passed. Please contact the Committee if you need to send evidence late. This sub-inquiry is part of the overarching: Brexit and the implications for UK business inquiry.
This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry.
The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements.
Evidence given by Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry, John Smith, Chief Executive, Propriety Association of Great Britain, Paul Fleming, Technical Director, British Generic Manufacturers AssociationMark Hicken, Managing Director UK & Ireland for Janssen, Pharmaceutical Companies of Johnson and Johnson, Peter Ballard. Managing Director, Xiromed
There are currently no public meetings scheduled.